9.81
price down icon2.87%   -0.29
after-market After Hours: 9.81
loading

Cullinan Therapeutics Inc Stock (CGEM) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
-
- -0.44 - -
Operating Expenses
5.49%
42.99
45.48 44.80 37.60 62.76
Operating Income/Loss
5.49%
-42.99
-45.48 -45.24 -37.60 -62.76
Income/Loss From Continuing Operations Before Tax
5.91%
-37.34
-39.69 -39.18 -32.21 -58.14
Income/Loss From Continuing Operations After Tax
46.07%
-37.34
-25.56 -39.18 -32.21 -58.14
Net Income/Loss
46.07%
-37.34
-25.56 -39.18 -32.21 -58.14
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
89.09%
-0.192
-1.76 - - -0.179
Basic Average Shares
10,141%
43.01
0.42 42.73 39.95 40.68
Diluted Average Shares
10,141%
43.01
0.42 42.73 39.95 40.68
Basic Earnings Per Share
59.26%
-0.86
-0.54 -0.91 -0.82 -1.42
Diluted Earnings Per Share
59.26%
-0.86
-0.54 -0.91 -0.82 -1.42
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$79.89
price up icon 2.27%
$32.25
price up icon 1.67%
$4.47
price down icon 5.10%
$353.31
price up icon 2.22%
biotechnology ONC
$221.22
price up icon 0.71%
$114.50
price down icon 0.67%
Cap:     |  Volume (24h):